HKU Scholars Hub: Browsing DSpace

Browsing by Author Ahn, MJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date	Views
	Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status Proceeding/Conference:Journal of Clinical Oncology	Gettinger, SN Zhang, S Graeme Hodgson, J Bazhenova, LA Burgers, S Kim, DW Tan, DS Koh, HA Ho, JCM Ramirez, SV Shaw, AT Weiss, GJ Langer, CJ Huber, RM Ahn, MJ Reichmann, WM Kerstein, D Rivera, VM Camidge, DR	2016	156
	KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma Proceeding/Conference:Annals of Oncology	Chan, ATC Lee, VHF Ngan, R To, KF Ahn, MJ Ng, QS Hong, RL Lin, JC Swaby, RF Gause, C Saraf, S Spreafico, A	2016	222
	KEYNOTE-495/KeyImPaCT: Interim Analysis of a Randomized, Biomarker-Directed, ProgramsPhase 2 Trial of Pembrolizumab-Based Combination Therapy for Non–Small Cell Lung Cancer Proceeding/Conference:The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021)	Gutierrez, M Lam, WS Hellmann, MD Gubens, MA Aggarwal, C Tan, DSW Felip, E Chiu, WYJ Lee, JS Yang, JCH Garon, EB Finocchiaro, G Ahn, MJ Luft, A Landers, GA Basso, A Ma, H Kobie, J Palcza, J Cristescu, R Fong, L Snyder, A Yuan, J Herbst, RS	2021	14
	Pembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study Proceeding/Conference:AHNS 9th International Conference of Head and Neck Cancer	Siu, LL Lee, VHF Ngan, R To, KF Ahn, MJ Ng, QS Hong, RL Lin, JC Swaby, RF Owtscharuk-Sheldon, T Saraf, S Chan, AT	2016	48

Showing results 1 to 4 of 4